Andrew Witty (Credit: Bloomberg)

Ex-GSK chief An­drew Wit­ty sum­moned back to the front­lines of vac­cine de­vel­op­ment at em­bat­tled WHO

Dur­ing his 10-year tenure at Glax­o­SmithK­line, An­drew Wit­ty made vac­cines one of his sig­na­ture ar­eas of fo­cus, lead­ing the phar­ma gi­ant to an ap­proval for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.